Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Oct;42(10):2590-4.
doi: 10.1128/AAC.42.10.2590.

Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus

Affiliations

Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus

H Aubry-Damon et al. Antimicrob Agents Chemother. 1998 Oct.

Abstract

Mutations in the rifampin resistance-determining (Rif) regions of the rpoB gene of Staphylococcus aureus mutants obtained during therapy or in vitro were analyzed by gene amplification and sequencing. Each of the resistant clinical isolates, including five nonrelated clones and two strains isolated from the same patient, and of the 10 in vitro mutants had a single base pair change that resulted in an amino acid substitution in the beta subunit of RNA polymerase. Eight mutational changes at seven positions were found in cluster I of the central Rif region. Certain substitutions (His481/Tyr and Asp471/Tyr [S. aureus coordinates]) were present in several mutants. Substitutions Gln468/Arg, His481/Tyr, and Arg484/His, which conferred high-level rifampin resistance, were identical or in the same codon as those described in other bacterial genera, whereas Asp550/Gly has not been reported previously. Substitutions at codon 477 conferred high- or low-level resistance, depending on the nature of the new amino acid. The levels of resistance of in vivo and one-step in vitro mutants carrying identical mutations were similar, suggesting that no other resistance mechanism was present in the clinical isolates. On the basis of these data and the population distribution of more than 4,000 clinical S. aureus isolates, we propose </=0.5 and >/=8 microg/ml as new breakpoints for the clinical categorization of this species relative to rifampin.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Distribution of rifampin MICs for 4,644 S. aureus strains isolated at Henri Mondor Hospital between 1993 and 1996.
FIG. 2
FIG. 2
Amino acid sequence comparison of the Rif regions of E. coli (Ec) and S. aureus (Sa). Clusters I, II, and III are indicated by dashed lines. Identical amino acids are indicated by asterisks, and gaps are indicated by dashes. Positions known to be involved in rifampin resistance in E. coli are indicated by downward-pointing arrows (mutations) or triangles (insertions) or are underlined (deletions). Mutations leading to low- and high-level rifampin resistance in S. aureus are indicated by single and double upward-pointing arrows, respectively.

References

    1. Aboshkiwa M, Rowland G, Coleman G. Nucleotide sequence of the Staphylococcus aureus RNA polymerase rpoB gene and comparison of its predicted amino acid sequence with those of other bacteria. Biochem Biophys Acta. 1995;1262:73–78. - PubMed
    1. Ackerman B H, Vannier A M, Eudy E B. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother. 1992;36:1766–1769. - PMC - PubMed
    1. Aubry-Damon H, Legrand P, Brun-Buisson C, Astier A, Soussy C-J, Leclercq R. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis. 1997;25:647–653. - PubMed
    1. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med. 1989;320:1188–1196. - PubMed
    1. Carter P E, Abadi F J R, Yakubu D E, Pennington T H. Molecular characterization of rifampin-resistant Neisseria meningitidis. Antimicrob Agents Chemother. 1994;38:1256–1261. - PMC - PubMed

Publication types

LinkOut - more resources